Close Menu

NEW YORK (GenomeWeb) – Cue Health said today that it has raised more than $45 million in Series B financing that it will use to complete development of its first set of diagnostic products, and fund a set of clinical studies to obtain US Food and Drug Administration 510(k) clearance for them.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.